Logos Global Management LP
Position in RVMD — Revolution Medicines, Inc.
CIK 1792126
San Francisco, CA
Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$194,500,000
+$35,200,000 QoQ
Shares Held
2,000,000
0.0% QoQ
Ownership
0.941%
of shares outstanding
% of Portfolio
10.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2025CallValue
$79,650,000
CallShares
1,000,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. RVMD ranks #1 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
This page
|
2,000,000 | $194,500,000 | |
| 2 | ERAS |
Erasca, Inc.
|
11,150,000 | $180,407,000 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
3,450,000 | $114,954,000 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
285,000 | $91,824,150 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
2,125,000 | $84,405,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
1,500,000 | $79,080,000 | |
| 7 | ABVX |
Abivax S.A.
|
675,000 | $75,161,250 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
3,000,000 | $62,760,000 |
All Filings in RVMD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $194,500,000 | 2,000,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $79,650,000 | 1,000,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $159,300,000 | 2,000,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $81,725,000 | 1,750,000 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $46,700,000 | 1,000,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $62,543,000 | 1,700,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,576,000 | 1,600,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,423,000 | 1,450,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,420,000 | 1,200,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $46,572,000 | 1,200,000 | Shares | Sole | 2024-08-27 | |
| 2023-12-31 | $10,038,000 | 350,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,920,000 | 250,000 | Shares | Sole | 2023-11-14 | |
| 2020-03-31 | $1,161,974 | 53,034 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||